이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

AcouSort 관리

관리 기준 확인 2/4

AcouSort's CEO는 Torsten Freltoft, Jan2014 에 임명되었습니다 의 임기는 10.42 년입니다. 는 SEK 90.67K 가치에 해당하는 회사 주식의 0.045% 직접 소유합니다. 90.67K. 경영진과 이사회의 평균 재임 기간은 각각 6.4 년과 7.8 년입니다.

주요 정보

Torsten Freltoft

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	10.5yrs
CEO 소유권	0.04%
경영진 평균 재임 기간	6.5yrs
이사회 평균 재임 기간	7.9yrs

최근 관리 업데이트

Recent updates

CEO

Torsten Freltoft (66 yo)

10.5yrs

테뉴어

SEK 503,359

보상

Mr. Torsten Freltoft, M.Sc., Ph D., has been the Chief Executive Officer of AcouSort AB and PlastiSens since 2014. Mr. Freltoft served as General Manager of Discovery Instruments of Biolin Scientific Holdi...

리더십 팀

이름	위치	테뉴어	보상	소유권
Torsten Freltoft	Chief Executive Officer	10.5yrs	SEK 503.36k	0.045% SEK 90.7k
Thomas Laurell	Founder & Independent Director	no data	데이터 없음	7.35% SEK 14.9m
Stefan Scheding	Founder & Independent Director	no data	데이터 없음	6.01% SEK 12.2m
Patrik Brundin	Founder	no data	데이터 없음	데이터 없음
Hans Lilja	Founder	no data	데이터 없음	데이터 없음
Gunnar Telhammar	Chief Financial Officer	6.5yrs	데이터 없음	데이터 없음
Henrik Johansson	Director of Research & Technology	1.1yrs	데이터 없음	데이터 없음

6.5yrs

평균 재임 기간

63yo

평균 연령

경험이 풍부한 관리: ACOU 의 관리팀은 노련하고 경험 (평균 재직 기간 6.4 년)입니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Thomas Laurell	Founder & Independent Director	13.5yrs	데이터 없음	7.35% SEK 14.9m
Stefan Scheding	Founder & Independent Director	12.5yrs	데이터 없음	6.01% SEK 12.2m
Katherine Flagg	Independent Board Member	2.6yrs	데이터 없음	데이터 없음
Martin Olin	Independent Chairman of the Board	3.3yrs	데이터 없음	0.080% SEK 161.9k

7.9yrs

평균 재임 기간

62yo

평균 연령

경험이 풍부한 이사회: ACOU 의 이사회는 경험(평균 재직 기간 7.8 년)으로 간주됩니다.

AcouSort 관리

관리 기준 확인 2/4

주요 정보

최근 관리 업데이트

Founder & Independent Director recently bought kr52k worth of stock

AcouSort AB (publ) Recruits Henrik Johansson to the Position as Director of Research and Technology

Founder & Independent Director recently bought kr68k worth of stock

AcouSort AB Announces Executive Appointments

Founder & Independent Director recently bought kr95k worth of stock

Recent updates

First quarter 2024 earnings released: kr0.25 loss per share (vs kr0.23 loss in 1Q 2023)

AcouSort AB (publ) to Present Two Posters Highlighting the Value of Acoustofluidics Sample Preparation

Full year 2023 earnings released: kr1.29 loss per share (vs kr1.04 loss in FY 2022)

New minor risk - Share price stability

Founder & Independent Director recently bought kr52k worth of stock

AcouSort AB (publ) to Report Q3, 2024 Results on Nov 27, 2024

New minor risk - Shareholder dilution

AcouSort AB (publ) has completed a Composite Units Offering.

Third quarter 2023 earnings released: kr0.33 loss per share (vs kr0.32 loss in 3Q 2022)

New major risk - Share price stability

AcouSort AB (publ) to Report Q4, 2023 Results on Feb 28, 2024

New major risk - Financial position

New minor risk - Share price stability

AcouSort (STO:ACOU) Is In A Good Position To Deliver On Growth Plans

AcouSort AB (publ) Recruits Henrik Johansson to the Position as Director of Research and Technology

First quarter 2023 earnings released: kr0.23 loss per share (vs kr0.20 loss in 1Q 2022)

AcouSort AB (publ) Launches Next Generation AcouTrap at CYTO 2023

Full year 2022 earnings released: kr0.98 loss per share (vs kr0.92 loss in FY 2021)

Founder & Independent Director recently bought kr68k worth of stock

Will AcouSort (STO:ACOU) Spend Its Cash Wisely?

Third quarter 2022 earnings released: kr0.32 loss per share (vs kr0.30 loss in 3Q 2021)

Second quarter 2022 earnings released: kr0.31 loss per share (vs kr0.31 loss in 2Q 2021)

The European Innovation Council Awards the Acousort Project Acousome SEK 26 Million to Develop Technology for Exosome-Based Diagnostics

AcouSort AB Announces Executive Appointments

We Think AcouSort (STO:ACOU) Can Afford To Drive Business Growth

AcouSort AB (publ) and Werfen's Joint Patent Application Has Received National Approval in US

AcouSort AB (publ) Announces Scientific Progress with AcouWash Enables New Method for Cancer Treatment Monitoring

First quarter 2022 earnings released: kr0.20 loss per share (vs kr0.15 loss in 1Q 2021)

Founder & Independent Director recently bought kr95k worth of stock

We're Hopeful That AcouSort (STO:ACOU) Will Use Its Cash Wisely

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

AcouSort AB (publ) to Report Fiscal Year 2021 Results on Apr 13, 2022

Third quarter 2021 earnings: Revenues and EPS in line with analyst expectations

AcouSort will launch AcouWash 2 at international conference

Second quarter 2021 earnings released: kr0.31 loss per share (vs kr0.12 loss in 2Q 2020)

AcouSort AB (publ) Announces Development Process of AcouPlasma Optical Reaches Important Milestone

First quarter 2021 earnings released: kr0.15 loss per share (vs kr0.10 loss in 1Q 2020)

We're Not Very Worried About AcouSort's (STO:ACOU) Cash Burn Rate

Acousort Strengthens Commercial Offering with the Release of New Acouwash Application Notes

Full year 2020 earnings released: kr0.70 loss per share (vs kr0.96 loss in FY 2019)

AcouSort AB (publ) to Report Fiscal Year 2020 Results on Apr 14, 2021

AcouSort AB (publ) to Report Q3, 2021 Results on Nov 24, 2021

AcouSort AB Enters Collaboration Agreement with Belgian Diagnostics Company

We Think AcouSort (STO:ACOU) Can Afford To Drive Business Growth

Physio-Tech Co.,Ltd. acquired AcouTrap system from AcouSort AB (publ) (OM:ACOU).

New 90-day high: kr26.90

New 90-day high: kr22.30

New 90-day high: kr21.80

Third quarter 2020 earnings released: kr0.20 loss per share

New 90-day high: kr19.25

New 90-day high: kr16.85

New 90-day high: kr12.40

CEO

테뉴어

보상

리더십 팀

평균 재임 기간

평균 연령

이사회 구성원

평균 재임 기간

평균 연령